FDA approves new antibacterial drug Zerbaxa

Washington, DC - The U.S. Food and Drug Administration today approved Zerbaxa (ceftolozane/tazobactam), a new antibacterial drug product, to treat adults with complicated intra-abdominal infections (cIAI) and complicated urinary tract infections (cUTI).

Read more...

CDC Year in Review: “Mission: Critical”

Washington, DC - It’s been an unprecedented year for the Centers for Disease Control and Prevention (CDC), as America’s public health agency continues its emergency response to the most complex Ebola epidemic in history. Ebola, however, is far from the only critical mission CDC undertook in 2014.

Read more...

FDA approves first pathogen reduction system to treat plasma

The U.S. Food and Drug Administration today approved the Intercept Blood System for plasma, the first pathogen reduction system for use by blood establishments in the preparation of plasma in order to reduce the risk of transfusion-transmitted infections (TTI).

Read more...

Justice Department's Civil Rights Division Issues Non-Discrimination Principles to Guide Federal, State and Local Governments' Response to the Ebola Virus

Washington, DC - The Justice Department’s Civil Rights Division issued non-discrimination principles today to guide federal, state and local governments’ response to the Ebola virus.  The division also issued guidance for protecting civil rights while responding to the Ebola virus and a reference guide on what legal protections may apply.

Read more...

More than 300 million people in at least 70 countries use smokeless tobacco

Washington, DC - The first-ever report on the global use and public health impact of smokeless tobacco finds that more than 300 million people in at least 70 countries use these harmful products. The report, Smokeless Tobacco and Public Health: A Global Perspective, is being released today by the CDC and the National Cancer Institute at the National Conference on Smoking or Health in Mumbai, India. Thirty-two leading experts from around the world contributed to the report.

Read more...